Autoantibodies, human T lymphotropic virus Type 1 and Type 1 diabetes mellitus in Jamaicans

West Indian Medical Journal

Volumn 51, Issue 3, 2002, Pages 153-156

  Smikle, M F ^a   Wright Pascoe, R ^a   Barton, E N ^a   Dowe, G ^a   Gilbert, D T ^a   Choo Kang, E ^a   Morgan, O St C ^a  

^a UNIVERSITY OF THE WEST INDIES   (Jamaica)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; GLUTAMATE DECARBOXYLASE ANTIBODY; INSULIN; PANCREAS ISLET CELL ANTIBODY;

ADOLESCENT; ADULT; AGE; ANAMNESIS; ANTIBODY SPECIFICITY; ARTICLE; AUTOIMMUNE DISEASE; BLOOD ANALYSIS; BLOOD DONOR; CLINICAL ARTICLE; CLINICAL FEATURE; COMORBIDITY; CONGENITAL RUBELLA SYNDROME; CONTROLLED STUDY; DISEASE DURATION; FEMALE; GRAVES DISEASE; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; INSULIN DEPENDENT DIABETES MELLITUS; JAMAICA; MALE; MEDICAL ASSESSMENT; MOLECULAR MECHANICS; PATHOGENESIS; SEROPREVALENCE;

ADULT; AUTOANTIBODIES; DIABETES MELLITUS, TYPE 1; FEMALE; GRAVES DISEASE; HTLV-I ANTIBODIES; HUMANS; JAMAICA; LEUKEMIA-LYMPHOMA, T-CELL, ACUTE, HTLV-I-ASSOCIATED; MALE; MIDDLE AGED; PARAPARESIS, TROPICAL SPASTIC; SEROEPIDEMIOLOGIC STUDIES;

EID: 0036759225     PISSN: 00433144     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Einsbarth GS. Type 1 diabetes mellitus: a chronic autoimmune disease. N Eng J Med 1986; 314: 1360-8.
2. 1,2 22 a novel isolated retrovirus and IDDM. Diabetes 1999; 48: 200-14.
3. Badenhoop K, Donner H, Neumann J, Herwig J, Kurth R, Usadel K et al. IDDM patients neither show humoral reactivities against endogenous retroviral envelop protein nor do they differ in retroviral mRNA expression from healthy relatives or normal individuals. Diabetes 1999; 48: 215-8.
4. Vyse TJ, Todd JA. Genetic analysis of autoimmune disease. Cell 1996; 85: 311-8.
5. Menser MA, Forrest JM, Bransby RD. Rubella infection and diabetes mellitus. Lancet 1978; 1: 57-60.
6. Wekerle H. The viral triggering of autoimmune disease. Coxsackie virus-induced autoimmune diabetes in mice. Nature Medicine 1998; 4: 770-1.
7. Conrad B, Weissmahr RN, Boni J, Acari R, Schiipbach J, Mach B. A human endogenous retroviral superantigen as candidate autoimmune gene in type 1 diabetes. Cell 1997; 90: 303-13.
8. 1,2 22 retrovirus is not detectable in either mRNA or genomic DNA from patients with type 1 diabetes. Diabetes 1999; 48: 219-22.
9. Diabetes Epidemiology Research International Group: Geographic patterns of childhood insulin-dependent diabetes mellitus. Diabetes 1988; 37: 1113-9.
10. Morrison E Y St A, Rosenbloom AL, McLaren NK, Riley WJ, Kooperman BS. Absence of islet cell autoantibodies in Jamaican Blacks with diabetes mellitus. West Indian Med J 1986; 35: 35-7.
11. Cotran RS, Kumar V, Robbins SL. Robbins pathologic basis of disease. 5th ed, Philadelphia: WB Saunders Co; 1994: 909.
12. Smikle MF, James OB. Seroprevalence of autoantibodies in selected and unselected populations in Jamaica. West Indian Med J 1994: 43: 59-62.
13. Murphy EL, Wilks R, Morgan OS, Hanchard B, Cranston B, Figueroa JP et al. Health effects of human T-lymphotropic virus type-1 (HTLV-1) in a Jamaican cohort. Int J Epidemiol 1996; 25: 1090-7.
14. Barton EN, Morgan O St C, Smikle MF and Blattner, WA. Seroprevalence of HTLV-1 in chronic disease patients in Jamaica. Trans Royal Soc Trop Med Hygiene 1994; 88: 410-11.
15. Gilbert DT, Morgan O St C, Smikle MF, Simeon D and Barton EN. HTLV-1 associated polymyositis in Jamaica. Acta Neurol Scand 2001; 103: 1-4.
16. WHO Expert Committee on Diabetes Mellitus, Second Report. Geneva: WHO Technical Report Series 1980; 646:1-80.
17. Kelly MA, Alvi NS, Croft NJ, Mijovic CH, Bottazzo GF, Barnett AH. Genetic and immunological characteristics of type 1 diabetes mellitus in an Indo-Aryan population. Diabetologia 2000; 43: 450-6.
18. Dubois-Laforgue J, Timsit J, Djilali-Saiah I, Boitard C, Caillat-Zucman S. Insulin-dependent diabetes mellitus in non-DR3/non-DR4 subjects. In: Charron D, ed. HLA: genetic diversity of HLA functional and medical implication. Paris: EDK; 1997: 610-13.
19. Hagopian WA, Lernmark C. Islet cell antibodies. In: Peter JB, Shoenfeld Y, eds. Autoantibodies. Amsterdam: Elsevier Science BV; 1996: 441-48.
20. Banerji MA, Chaiken RL, Huey H, Tiinamaija T, Norin AJ, MacKay IR et al. GAD antibody negative NIDDM in adult black subjects with diabetic ketoacidosis and increased frequency of human leukocyte antigen DR3 and DR4: flatbush diabetes. Diabetes 1994; 43: 741-5.
21. Schmidli RS, DeAizpurua HJ, Harison LC, Colman PG. Antibodies to glutamic acid decarboxylase in at-risk and clinical insulin-dependent diabetic subjects: relationship to age, sex and islet cell antibody status and temporal profile. J Autoimmunity 1994; 7: 55-66.
22. Mijovic CH, Jenkins D, Jacobs KH, Penny MA, Fletcher JA, Barnett AH. HLA-DQA1 and DQA1 and -DQB1 alleles associated with genetic susceptibility to IDDM in a Black population. Diabetes 1991; 40: 748-51.
23. Mine H, Kawai H, Yokoi K, Akaike M, Saito S. High frequencies of human T lymphotropic virus type 1 (HTLV-1) proviral DNA in blood donors with anti-thyroid antibodies. J Molecular Med 1996; 74: 471-7.
24. Nishioka K. HTLV-1 arthropathy and Sjögren's syndrome. J AIDS Hum Retroviruses 1996; 13 (Suppl):S57-S62.
25. Daenke S, Bangham CRM. Do T cells cause HTLV-1 associated disease?: a taxing problem. Clin Exp Immunol 1994; 96: 179-81.
26. Smikle MF, Barton EN, Morgan O St C, Luseko J, Bailey VE, Williams EM. The significance of immune disorder in tropical spastic paraparesis. Human Antibodies 1999; 9: 133-7.